Do analysts recommend CO or CYH?

Community Health Systems has a consensus price target of $2.96, suggesting a potential downside of 2.01%. Given Community Health Systems' stronger consensus rating and higher possible upside, analysts clearly believe Community Health Systems is more favorable than Global Cord Blood. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Community Health Systems 3 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.75

Do analysts prefer CO or AUNA?

Auna has a consensus price target of $6.97, indicating a potential upside of 28.06%. Given Auna's stronger consensus rating and higher possible upside, analysts clearly believe Auna is more favorable than Global Cord Blood. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Auna 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.40

Do analysts rate CO or VMD?

Viemed Healthcare has a consensus target price of $14.00, indicating a potential upside of 44.18%. Given Viemed Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Viemed Healthcare is more favorable than Global Cord Blood. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Viemed Healthcare 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25

Do analysts rate TACO or CO?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation & earnings, TACO or CO?

Global Cord Blood has higher revenue and earnings than Berto Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A Global Cord Blood $1.24B 0.09 $79.04M $0.64 1.49

Is TACO or CO more profitable?

Company Net Margins Return on Equity Return on Assets Berto Acquisition N/A N/A N/A Global Cord Blood N/A N/A N/A

Global Cord Blood (CO) Competitors

$0.95 0.00 (0.00%)

As of 10/15/2026

Compare

CO vs. SRTA, CYH, AUNA, VMD, and TACO

Should you buy Global Cord Blood stock or one of its competitors? Global Cord Blood's main competitors and comparable companies include Strata Critical Medical (SRTA), Community Health Systems (CYH), Auna (AUNA), Viemed Healthcare (VMD), and Berto Acquisition (TACO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Global Cord Blood compare to Strata Critical Medical?

Strata Critical Medical (NASDAQ:SRTA) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends.

47.4% of Strata Critical Medical shares are held by institutional investors. 15.5% of Strata Critical Medical shares are held by company insiders. Comparatively, 0.5% of Global Cord Blood shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Global Cord Blood has higher revenue and earnings than Strata Critical Medical. Strata Critical Medical is trading at a lower price-to-earnings ratio than Global Cord Blood, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Strata Critical Medical	$255.98M	1.58	$41.35M	-$0.04	N/A
Global Cord Blood	$1.24B	0.09	$79.04M	$0.64	1.49

In the previous week, Strata Critical Medical had 1 more articles in the media than Global Cord Blood. MarketBeat recorded 1 mentions for Strata Critical Medical and 0 mentions for Global Cord Blood. Strata Critical Medical's average media sentiment score of 1.76 beat Global Cord Blood's score of 0.00 indicating that Strata Critical Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Strata Critical Medical	Very Positive
Global Cord Blood	Neutral

Strata Critical Medical has a beta of 2.43, indicating that its share price is 143% more volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, indicating that its share price is 84% less volatile than the broader market.

Strata Critical Medical currently has a consensus target price of $8.00, suggesting a potential upside of 74.56%. Given Strata Critical Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Strata Critical Medical is more favorable than Global Cord Blood.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Strata Critical Medical	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75
Global Cord Blood	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Strata Critical Medical has a net margin of 15.71% compared to Global Cord Blood's net margin of 0.00%. Global Cord Blood's return on equity of 0.00% beat Strata Critical Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Strata Critical Medical	15.71%	-2.97%	-2.54%
Global Cord Blood	N/A	N/A	N/A

Summary

Strata Critical Medical beats Global Cord Blood on 11 of the 17 factors compared between the two stocks.

How does Global Cord Blood compare to Community Health Systems?

Global Cord Blood (NYSE:CO) and Community Health Systems (NYSE:CYH) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

In the previous week, Community Health Systems had 4 more articles in the media than Global Cord Blood. MarketBeat recorded 4 mentions for Community Health Systems and 0 mentions for Global Cord Blood. Community Health Systems' average media sentiment score of 0.26 beat Global Cord Blood's score of 0.00 indicating that Community Health Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
Global Cord Blood	Neutral
Community Health Systems	Neutral

Community Health Systems has a consensus price target of $2.96, suggesting a potential downside of 2.01%. Given Community Health Systems' stronger consensus rating and higher possible upside, analysts clearly believe Community Health Systems is more favorable than Global Cord Blood.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Cord Blood	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Community Health Systems	3 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.75

Global Cord Blood has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market. Comparatively, Community Health Systems has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market.

85.0% of Community Health Systems shares are held by institutional investors. 0.5% of Global Cord Blood shares are held by insiders. Comparatively, 11.1% of Community Health Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Community Health Systems has higher revenue and earnings than Global Cord Blood. Global Cord Blood is trading at a lower price-to-earnings ratio than Community Health Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Cord Blood	$1.24B	0.09	$79.04M	$0.64	1.49
Community Health Systems	$12.49B	0.03	$509M	$1.85	1.63

Community Health Systems has a net margin of 2.10% compared to Global Cord Blood's net margin of 0.00%. Global Cord Blood's return on equity of 0.00% beat Community Health Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Global Cord Blood	N/A	N/A	N/A
Community Health Systems	2.10%	-6.66%	0.62%

Summary

Community Health Systems beats Global Cord Blood on 14 of the 16 factors compared between the two stocks.

How does Global Cord Blood compare to Auna?

Global Cord Blood (NYSE:CO) and Auna (NYSE:AUNA) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

Global Cord Blood has higher revenue and earnings than Auna. Global Cord Blood is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Cord Blood	$1.24B	0.09	$79.04M	$0.64	1.49
Auna	$1.23B	0.33	$27.39M	$0.07	77.71

Auna has a net margin of 0.44% compared to Global Cord Blood's net margin of 0.00%. Auna's return on equity of 12.88% beat Global Cord Blood's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Global Cord Blood	N/A	N/A	N/A
Auna	0.44%	12.88%	3.24%

Global Cord Blood has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market. Comparatively, Auna has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market.

Auna has a consensus price target of $6.97, indicating a potential upside of 28.06%. Given Auna's stronger consensus rating and higher possible upside, analysts clearly believe Auna is more favorable than Global Cord Blood.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Cord Blood	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

In the previous week, Auna had 1 more articles in the media than Global Cord Blood. MarketBeat recorded 1 mentions for Auna and 0 mentions for Global Cord Blood. Global Cord Blood's average media sentiment score of 0.00 equaled Auna'saverage media sentiment score.

Company	Overall Sentiment
Global Cord Blood	Neutral
Auna	Neutral

Summary

Auna beats Global Cord Blood on 11 of the 14 factors compared between the two stocks.

How does Global Cord Blood compare to Viemed Healthcare?

Global Cord Blood (NYSE:CO) and Viemed Healthcare (NASDAQ:VMD) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

In the previous week, Viemed Healthcare had 1 more articles in the media than Global Cord Blood. MarketBeat recorded 1 mentions for Viemed Healthcare and 0 mentions for Global Cord Blood. Viemed Healthcare's average media sentiment score of 0.91 beat Global Cord Blood's score of 0.00 indicating that Viemed Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Global Cord Blood	Neutral
Viemed Healthcare	Positive

Global Cord Blood has higher revenue and earnings than Viemed Healthcare. Global Cord Blood is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Cord Blood	$1.24B	0.09	$79.04M	$0.64	1.49
Viemed Healthcare	$270.28M	1.37	$14.93M	$0.36	26.97

74.2% of Viemed Healthcare shares are owned by institutional investors. 0.5% of Global Cord Blood shares are owned by company insiders. Comparatively, 20.6% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Viemed Healthcare has a consensus target price of $14.00, indicating a potential upside of 44.18%. Given Viemed Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Viemed Healthcare is more favorable than Global Cord Blood.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Cord Blood	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Viemed Healthcare	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

Viemed Healthcare has a net margin of 4.81% compared to Global Cord Blood's net margin of 0.00%. Viemed Healthcare's return on equity of 10.16% beat Global Cord Blood's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Global Cord Blood	N/A	N/A	N/A
Viemed Healthcare	4.81%	10.16%	7.22%

Global Cord Blood has a beta of 0.16, indicating that its stock price is 84% less volatile than the broader market. Comparatively, Viemed Healthcare has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market.

Summary

Viemed Healthcare beats Global Cord Blood on 13 of the 16 factors compared between the two stocks.

How does Global Cord Blood compare to Berto Acquisition?

Berto Acquisition (NASDAQ:TACO) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Berto Acquisition has a beta of 0.08, suggesting that its stock price is 92% less volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, suggesting that its stock price is 84% less volatile than the broader market.

Global Cord Blood has higher revenue and earnings than Berto Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
Global Cord Blood	$1.24B	0.09	$79.04M	$0.64	1.49

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
Global Cord Blood	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Global Cord Blood	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Berto Acquisition had 3 more articles in the media than Global Cord Blood. MarketBeat recorded 3 mentions for Berto Acquisition and 0 mentions for Global Cord Blood. Berto Acquisition's average media sentiment score of 1.56 beat Global Cord Blood's score of 0.00 indicating that Berto Acquisition is being referred to more favorably in the media.

Company	Overall Sentiment
Berto Acquisition	Very Positive
Global Cord Blood	Neutral

Summary

Berto Acquisition beats Global Cord Blood on 3 of the 5 factors compared between the two stocks.

Get Global Cord Blood News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CO vs. The Competition

Export

Metric	Global Cord Blood	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$115.60M	$10.41B	$7.36B	$23.13B
Dividend Yield	N/A	2.60%	2.51%	3.72%
P/E Ratio	1.49	33.97	274.15	28.15
Price / Sales	0.09	4.79	624.75	12.81
Price / Cash	4.19	115.42	76.19	35.33
Price / Book	0.15	5.07	10.29	4.69
Net Income	$79.04M	$315.68M	$3.50B	$1.07B
7 Day Performance	N/A	-1.26%	-5.37%	-0.82%
1 Month Performance	N/A	-5.60%	-8.55%	-2.63%
1 Year Performance	N/A	9.92%	0.43%	6.54%

Global Cord Blood Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CO Global Cord Blood	N/A	$0.95 flat	N/A	N/A	$115.60M	$1.24B	1.49	1,202
SRTA Strata Critical Medical	2.5091 of 5 stars	$4.55 +1.7%	$8.00 +76.0%	N/A	$402.10M	$197.14M	N/A	601	Positive News Gap Up
CYH Community Health Systems	2.3068 of 5 stars	$2.77 +1.3%	$2.96 +7.0%	-2.6%	$389.89M	$11.98B	1.49	57,000	Analyst Downgrade
AUNA Auna	3.7989 of 5 stars	$5.12 +0.3%	$6.97 +36.2%	-19.1%	$378.58M	$4.67B	73.08	15,254
VMD Viemed Healthcare	4.0838 of 5 stars	$9.53 +1.3%	$14.00 +46.9%	+41.5%	$362.22M	$301.61M	26.42	1,382	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CO) was last updated on 10/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Global Cord Blood (CO) Competitors

CO vs. SRTA, CYH, AUNA, VMD, and TACO

How does Global Cord Blood compare to Strata Critical Medical?

Summary

How does Global Cord Blood compare to Community Health Systems?

Summary

How does Global Cord Blood compare to Auna?

Summary

How does Global Cord Blood compare to Viemed Healthcare?

Summary

How does Global Cord Blood compare to Berto Acquisition?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CO vs. The Competition

Global Cord Blood Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Global Cord Blood (CO) Competitors

CO vs. SRTA, CYH, AUNA, VMD, and TACO

How does Global Cord Blood compare to Strata Critical Medical?

Do institutionals & insiders have more ownership in SRTA or CO?

Which has preferable earnings & valuation, SRTA or CO?

Does the media prefer SRTA or CO?

Which has more volatility and risk, SRTA or CO?

Do analysts recommend SRTA or CO?

Is SRTA or CO more profitable?

Summary

How does Global Cord Blood compare to Community Health Systems?

Does the media favor CO or CYH?

Do analysts recommend CO or CYH?

Which has more risk & volatility, CO or CYH?

Do institutionals & insiders have more ownership in CO or CYH?

Which has preferable earnings and valuation, CO or CYH?

Is CO or CYH more profitable?

Summary

How does Global Cord Blood compare to Auna?

Which has stronger earnings & valuation, CO or AUNA?

Is CO or AUNA more profitable?

Which has more risk and volatility, CO or AUNA?

Do analysts prefer CO or AUNA?

Does the media prefer CO or AUNA?

Summary

How does Global Cord Blood compare to Viemed Healthcare?

Does the media favor CO or VMD?

Which has better valuation & earnings, CO or VMD?

Do institutionals & insiders hold more shares of CO or VMD?

Do analysts rate CO or VMD?

Is CO or VMD more profitable?

Which has more risk and volatility, CO or VMD?

Summary

How does Global Cord Blood compare to Berto Acquisition?

Which has more volatility and risk, TACO or CO?

Which has stronger valuation & earnings, TACO or CO?

Is TACO or CO more profitable?

Do analysts rate TACO or CO?

Does the media favor TACO or CO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CO vs. The Competition

Global Cord Blood Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools